Circulating tumor DNA and tissue complementarily detect genomic alterations in metastatic hormone-sensitive prostate cancer
Summary: The clinical utility of circulating tumor DNA (ctDNA) in hormone-sensitive prostate cancer (HSPC) remains inadequately elucidated. This study presents the largest real-world cohort to conduct a concordance analysis between ctDNA and tissue-based genomic profiling in HSPC patients. The findi...
Main Authors: | Bin Yang, Tingting Zhao, Baijun Dong, Wei Chen, Guanjie Yang, Jun Xie, Changcheng Guo, Ruiliang Wang, Hong Wang, Longfei Huang, Bo Peng, Wei Xue, Xudong Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004224001524 |
Similar Items
-
Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer
by: Xinxing Du, et al.
Published: (2023-08-01) -
Blindly verifying partially unknown entanglement
by: Ming-Xing Luo, et al.
Published: (2022-03-01) -
A parameter-independent algorithm of finding maximum clique with Seidel continuous-time quantum walks
by: Xi Li, et al.
Published: (2024-02-01) -
A terahertz near-field nanoscopy revealing edge fringes with a fast and highly sensitive quantum-well photodetector
by: Fucheng Qiu, et al.
Published: (2022-07-01) -
Quantum tunneling of hydrogen atom transfer affects mandrel degradation in inertial confinement fusion target fabrication
by: Yu Zhu, et al.
Published: (2022-01-01)